Design and Docking Studies of Peptide Inhibitors as Potential Antiviral Drugs for Dengue Virus Ns2b/Ns3 Protease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5305|21|8|815-827

ISSN： 0929-8665

Source： Protein and Peptide Letters, Vol.21, Iss.8, 2014-06, pp. : 815-827

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus

By Frecer V.   Kabelac M.   De Nardi P.   Pricl S.   Miertus S.  

Journal of Molecular Graphics and Modelling, Vol. 22, Iss. 3, 2004-01 ,pp. : 209-220

Elsevier

Access to resources Recommend Favorite

Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3

By Poliakov Anton   Sandström Anja   Åkerblom Eva   Danielson U. Helena  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 22, Iss. 2, 2007-04 ,pp. : 191-199

Informa Healthcare

Access to resources Recommend Favorite

Catalytically active Dengue virus NS3 protease forms aggregates that are separable by size exclusion chromatography

By Arakaki T.L.   Fang N-X.   Fairlie D.P.   Young P.R.   Martin J.L.  

Protein Expression and Purification, Vol. 25, Iss. 2, 2002-07 ,pp. : 241-247

Academic Press

Access to resources Recommend Favorite

Complex Formation of NS5B with NS3 and NS4A Proteins of Hepatitis C Virus

By Ishido S.   Fujita T.   Hotta H.  

Biochemical and Biophysical Research Communications, Vol. 244, Iss. 1, 1998-03 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

An Uniquely Purified HCV NS3 Protease and NS4A21–34 Peptide Form a Highly Active Serine Protease Complex in Peptide Hydrolysis

By Sardana V.V.   Blue J.T.   Zugay-Murphy J.   Sardana M.K.   Kuo L.C.  

Protein Expression and Purification, Vol. 16, Iss. 3, 1999-08 ,pp. : 440-447

Academic Press

Access to resources Recommend Favorite